Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 7.50% is 62% below its 5-year average of 19.91%, near the low end of its 5-year range (7.50%–27.99%).
As of the fiscal period ended Tuesday, June 30, 2026. 42.94% below its 12-month average of 13.14%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.50%.
DEBT TO ASSETS RATIO
7.50%
DEBT TO ASSETS RATIO AVG TTM
13.14%
DEBT TO ASSETS RATIO AVG 3Y
19.60%
DEBT TO ASSETS RATIO AVG 5Y
19.91%
DEBT TO ASSETS RATIO AVG 10Y
16.97%
DEBT TO ASSETS RATIO AVG 15Y
12.42%
DEBT TO ASSETS RATIO AVG 20Y
13.12%
CURRENT VS TTM AVG
-42.94%
CURRENT VS 3Y AVG
-61.76%
CURRENT VS 5Y AVG
-62.35%
CURRENT VS 10Y AVG
-55.83%
CURRENT VS 15Y AVG
-39.62%
CURRENT VS 20Y AVG
-42.87%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+8230.16%
vs the sector median at left
Cumberland Pharmaceuticals Inc.
Market Cap
$105.63M
Debt to Assets Ratio
7.50%
TTM Avg
13.14%
3Y Avg
19.60%
5Y Avg
19.91%
Market Cap
$105.79M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$104.72M
Debt to Assets Ratio
0.34%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$104.67M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$104.29M
Debt to Assets Ratio
0.14%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$107.41M
Debt to Assets Ratio
0.70%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$107.79M
Debt to Assets Ratio
0.43%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$102.40M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cumberland Pharmaceuticals Inc. (CPIX) | $105.63M | 7.50% | 13.14% | 19.60% | 19.91% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $105.79M | 0.03% | N/A | N/A | N/A |
| Definitive Healthcare Corp. (DH)vs › | $104.72M | 0.34% | N/A | N/A | N/A |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.67M | 0.00% | N/A | N/A | N/A |
| Immunic, Inc. (IMUX)vs › | $106.66M | 0.00% | N/A | N/A | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $104.29M | 0.14% | N/A | N/A | N/A |
| Outlook Therapeutics, Inc. (OTLK)vs › | $107.41M | 0.70% | N/A | N/A | N/A |
| Vivani Medical, Inc. (VANI)vs › | $107.79M | 0.43% | N/A | N/A | N/A |
| Anixa Biosciences, Inc. (ANIX)vs › | $102.40M | 0.01% | N/A | N/A | N/A |
| The Joint Corp. (JYNT)vs › | $102.21M | 0.04% | N/A | N/A | N/A |
Debt/Assets
7.5%
Debt/Equity
0.27
Current Ratio
0.96
Interest Coverage
-5.6x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 7.50% |
| 2026-03-31 | 14.18% |
| 2025-12-31 | 13.25% |
| 2025-09-30 | 15.54% |
| 2025-06-30 | 15.23% |
| 2025-03-31 | 14.93% |
| 2024-12-31 | 27.22% |
| 2024-09-30 | 27.99% |
| 2024-06-30 | 27.47% |
| 2024-03-31 | 26.56% |
| 2023-12-31 | 22.54% |
| 2023-09-30 | 21.25% |
| 2023-06-30 | 21.20% |
| 2023-03-31 | 23.23% |
| 2022-12-31 | 22.55% |
| 2022-09-30 | 19.75% |
| 2022-06-30 | 21.09% |
| 2022-03-31 | 21.50% |
| 2021-12-31 | 19.01% |
| 2021-09-30 | 18.64% |
| 2021-06-30 | 17.54% |
| 2021-03-31 | 18.03% |
| 2020-12-31 | 19.97% |
| 2020-09-30 | 20.12% |
| 2020-06-30 | 20.04% |
| 2020-03-31 | 21.84% |
| 2019-12-31 | 20.56% |
| 2019-09-30 | 19.27% |
| 2019-06-30 | 18.60% |
| 2019-03-31 | 17.45% |
| 2018-12-31 | 17.75% |
| 2018-09-30 | 13.72% |
| 2018-06-30 | 13.27% |
| 2018-03-31 | 13.17% |
| 2017-12-31 | 10.51% |
| 2017-09-30 | 8.85% |
| 2017-06-30 | 7.63% |
| 2017-03-31 | 4.46% |
| 2016-12-31 | 4.39% |
| 2016-09-30 | 4.06% |
| 2016-06-30 | 3.98% |
| 2016-03-31 | 1.91% |
| 2015-12-31 | 1.85% |
| 2015-09-30 | 1.85% |
| 2015-06-30 | 1.83% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 5.29% |
| 2013-06-30 | 6.14% |
| 2013-03-31 | 4.44% |
| 2012-12-31 | 4.42% |
| 2012-09-30 | 5.10% |
| 2012-06-30 | 4.57% |
| 2012-03-31 | 6.94% |
| 2011-12-31 | 5.09% |
| 2011-09-30 | 5.38% |
| 2011-06-30 | 6.80% |
| 2011-03-31 | 7.76% |
| 2010-12-31 | 7.78% |
| 2010-09-30 | 8.95% |
| 2010-06-30 | 8251.68% |
| 2010-03-31 | 15.74% |
| 2009-12-31 | 19.43% |
| 2009-09-30 | 19.88% |
| 2009-06-30 | 19.22% |
| 2009-03-31 | 23.43% |
| 2008-12-31 | 21.93% |
| 2008-09-30 | 10.54% |
| 2008-06-30 | 12.77% |
| 2008-03-31 | 11.81% |
| 2007-12-31 | 14.09% |
| 2007-09-30 | 16.12% |
| 2007-06-30 | 17.75% |
| 2007-03-31 | 18.44% |
| 2006-12-31 | 20.43% |
